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Integrin avb8 Adopts a High Afﬁnity State for Soluble
Ligands Under Physiological Conditions
Ping Hu and Bing-Hao Luo*
Department of Biological Sciences, Louisiana State University, Baton Rouge, Louisiana

ABSTRACT
It has been proposed that integrins adopt a low afﬁnity conformation under physiological conditions. Integrin can either be activated through
cytoplasm or by binding of cations such as Mn2þ to the head domain. The cytoplasmic activation pathway, that is, inside-out signaling has
been regarded as the physiological pathway for integrin activation. Integrin b8 is important for neuron vascular development. However, due to
the highly divergent cytoplasmic domain, this integrin probably does not rely on inside-out signaling for afﬁnity regulation. We therefore
hypothesized that the b8 integrin uniquely assumes a constitutively high afﬁnity state under physiological conditions. We discovered that b8
indeed exhibited high binding to soluble vitronectin in the presence of Ca2þ and the ligand binding could not be further enhanced by addition
of Mn2þ. The lower ectodomain stalk of the integrin, which is comprised by the integrin epidermal growth factor-like (I-EGF) domains and bTD
domain, is critical for this high afﬁnity conformation. In addition, we found that unlike other integrins, Mg2þ at low concentration inhibited b8
ligand binding. Mutagenesis studies indicated that b8 integrin possesses a unique cation binding site which might contribute to the ligand
binding afﬁnity. Our study showed that both the b8 lower ectodomain stalk and the head domain play an important role in its high afﬁnity state
under physiological conditions. J. Cell. Biochem. 118: 2044–2052, 2017. © 2016 Wiley Periodicals, Inc.
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ntegrins are a-b heterodimeric cell surface adhesive receptors
that play important roles in many biological functions including
cell migration, proliferation, differentiation, and survival [Hynes,
2002]. At least twenty-four integrins, which are composed of
eighteen a and eight b subunits, have been identiﬁed in vertebrates
[Humphries et al., 2006]. Different integrins have diverse functions
due to distinct submembrane linkers to cytoskeleton and intracellular proteins as well as different ligand-binding speciﬁcities and
afﬁnities. Integrin avb8, is distinctive among the integrins. This
integrin is almost exclusively expressed in the central and peripheral
nervous systems and placenta. The b8 integrin expression is
correlated with central nervous system (CNS) development
[Chernousov and Carey, 2003]. avb8 also regulates TGF-b1
activation and uniquely aids in the repair of neural cells, especially
Schwann cells, by binding to ECM ligands and inducing growth,
differentiation, and healing. The integrin is essential for embryonic
development as b8 knock-out mice exhibited embryonic or perinatal
lethality with abnormal vascular development [Zhu et al., 2002;
Proctor et al., 2005]. Lack of interaction between latent TGF-b1 and
avb8, which is required for TGF-b1 activation, has been proposed to
be the cause of these defects [Mobley et al., 2009]. Despite its

interactions with vitronectin, the b8 integrin was reported as a nonadhesive receptor [Nishimura et al., 1994]. Later studies found that
the b8 cytoplasmic domain is completely different from other av
partners, including b1, b3, b5, and b6, which may explain why this
integrin does not mediate cell adhesion like its siblings.
Integrins are considered as special adhesive receptors because
their adhesiveness can be dynamically regulated through a process
termed inside-out signaling. On the cell surface, integrins normally
adopt a low afﬁnity state, which can be switched into high afﬁnity
state through inside-out signaling. Binding of the integrin
extracellular ligands in turn transmits signals inward, a process
called outside-in signaling, which exerts signiﬁcant inﬂuences on
cell mobility, proliferation, and differentiation, etc. [Ginsberg
et al., 2005]. It has been shown that many integrins, including the
b3 integrin, can transmit these bidirectional signals across the
plasma membrane. However, the b8 cytoplasmic domain lacks all
the protein–protein interaction sites that have been identiﬁed on
the b3 cytoplasmic domain and shows little homology to other av
pairing partners. This fact implicates that either the b8 integrin
does not rely on inside-out signaling as other integrins or it uses a
completely different set of machinery for cytosolic activation.
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Likewise, the integrin probably mediates a distinct outside-in
signaling.
It has been proposed that integrin afﬁnity is regulated through
global conformational changes of the integrin extracellular domains
[Luo and Springer, 2006; Luo et al., 2007]. Many studies suggest that
integrins exist on the cell surface as three different conformational
states: bent, extended-closed, and extended-open. In the crystal
structures of the full length ectodomains of avb3 [Xiong et al., 2001,
2002, 2009; Dong et al., 2012], aIIbb3 [Zhu et al., 2008], and aXb2
[Xie et al., 2010], integrins are all in the bent conformation with the
a- and b-subunit C-termini only a few angstroms apart, consistent
with association of the a- and b-subunit transmembrane (TM)
domains. It was hypothesized that this bent conformation represents
a resting, low afﬁnity state, and inside-out activating signals induce
separation of the integrin TM and cytoplasmic domains followed by
separation of two ectodomain lower stalks and extension of these
two legs [Wang and Luo, 2010; Ye et al., 2011; Hu and Luo, 2013].
Integrin extension then results in swing-out of the b-subunit hybrid
domain, which causes the downward movement of the a7 helix of
the b-I domain, leading to exposure of the ligands binding site and
high afﬁnity for soluble ligand binding [Luo et al., 2007]. Even
though the activating model has been supported by numerous
experimental data, it is still unclear whether every integrin assumes a
bent conformation with low afﬁnity for ligands under physiological
conditions and goes through activation during integrin signaling.
Based on previous studies [Mu et al., 2002], we proposed that the b8
integrin might be an exception, which could adopt a conformation
with high afﬁnity for soluble ligands under physiological conditions.
In addition to global conformational changes, cations also play a
critical role in regulating integrin afﬁnity by interacting with the
three ion binding sites [Luo et al., 2007; Campbell and Humphries,
2011]. The metal ion depend adhesion site (MIDAS) sits in the middle
and is ﬂanked by adjacent to MIDAS (ADMIDAS) and synergistic
metal ion binding site (SyMBS) [Campbell and Humphries, 2011].
The MIDAS functions as a key interacting site for integrin ligands as
the cation bound in the site condinates binding of the ligands to
integrin through interacting the carboxyl group of the ligands. In
contrast, ADMIDAS has been reported as a negative regulatory site
for ligand–integrin interaction. The inhibitory effect of Ca2þ
occupancy in ADMIDAS has been observed in various integrins
including b7 [Chen et al., 2003], b1 [Mould et al., 2003; Valdramidou
et al., 2008], and b3 [Pesho et al., 2006]. ADMIDAS mutations
increased afﬁnity in ligand binding for rolling-mediating integrins
and inhibited ligand binding in integrins that only mediate ﬁrm
adhesion [Raborn et al., 2011; Zhang and Chen, 2012]. These
conﬂicting results could be caused by a single residue difference
located in MIDAS, implicating a critical role of the ion binding sites
in diverse functions of integrins [Raborn and Luo, 2012; Raborn
et al., 2013]. Among the ions that interact with the bI domain, Mg2þ
is known to bind to MIDAS [Zhu et al., 2008] whereas Ca2þ can bind
to all the three sites but with higher afﬁnity toward SyMBS and
ADMIDAS [Chen et al., 2003; Pesho et al., 2006].
In this study, we expressed the avb8 integrin in HEK293T cells,
and showed that this integrin bound soluble ligands much better
than the b3 integrin under physiological conditions. Follow up
studies indicated that the lower leg of b8 integrin is crucial in this
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constitutively high ligand binding. Furthermore, we discovered that
unlike most other integrins, Mg2þ in the low concentration inhibited
binding of the integrin to its natural ligand vitronectin. Alignment
and mutagenesis study unveiled a distinct ADMIDAS on b8 integrin,
which contributes to the inherent high afﬁnity for soluble ligands of
the integrin. Our study suggested that both the lower stalk and cation
binding sites on the integrin head are important for the high afﬁnity
conformation of the b8 integrin.

EXPERIMENTAL PROCEDURES
CELLS AND PLASMIDS
HEK293T cells (American Type Culture Collection, Manassas, VA)
were maintained in DMEM medium (Life Technologies, Grand Island,
NY) supplemented with 10% FBS, 1% Non-Essential Amino Acids,
1% L-Glutamine, 1% Sodium Pyruvate, and 1% Penicillin–
Streptomycin (all from Life Technologies). Plasmids containing
wild-type human integrin av and b3 were described previously
[Takagi et al., 2002]. Wild-type b8 integrin was generously gifted by
Dr. Nishimura [Nishimura et al., 1994]. All of the chimera constructs
were created via overlap PCR and the mutants were created by
QuikChange kit (Stratagene, La Jolla, CA).
CHIMERIC INTEGRIN CONSTRUCTION
The integrin chimeras were generated by replacing different regions
of b3 with the corresponding regions on b8. The chimera b3b8Leg
was constructed by replacing the b3 residues 461–788 with b8
468–769 (whole lower leg swapping). Brieﬂy, the DNA fragment
coding the b3 integrin head domain (PSI, bI, and hybrid domains)
was produced by using a forward primer: AGACTAGTACCATGCGAGCGCGGCCGCG and an overlapping reverse primer which
contains part of the b8 EGF1 domain: GTCCTCTGTTGTCCTCACACTGACAGTCACAATCAAAGGTGACCTGGACG. Likewise, the leg
domain fragment of b8 was created using an overlapping forward
primer which contains part of the b3 hybrid domain: CGTCCAGGTCACCTTTGATTGTGACTGTCAGTGTGAGGACAACAGAGGAC and a
reverse primer of b8: GGATATCTTAGAAGTTGCACCTGAAAGTTTC.
The PCR reaction was performed by using Phusion1 high-ﬁdelity
DNA polymerase (New England Biolabs, Ipswich, MA). The two
fragments were then fused together and ampliﬁed by adding both the
forward primer of b3 and the reverse primer of b8. The chimeric
cDNA was then puriﬁed and subcloned into PCDNA3.1 vector.
Similarly, the b3b8 TM-Cyt chimera was created by replacing b3
717–788 with b8 680–769 using following primers: TGATGAAAAATATTCTCAAGTAGCTAGGGCCCTTGGGACACTCTGGCTCT and AGA
GCCAGAGTGTCCCAAGGGCCCTAGCTACTTGAGAATATTTTTCAT
CA. The b3b8EGF-bTD chimera was created by replacing b3
461–717 with b8 468–680 and following primers were used:
CTGAGAGCAGGACCACCAGGATGTCTGGGCTGGAGAAACATTCTGAAGTT and AACTTCAGAATGTTTCTCCAGCCCAGACATCCTGGTG
GTCCTGCTCTCAG.
TRANSIENT TRANSFECTION
Constructs were transiently transfected into HEK293T cells using
X-tremegene 9 transfection kit (Roche Diagnostics, Indianapolis, IN).
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The expression levels of the wild-type integrins, the chimeras, and
the mutants were determined by ﬂow cytometry staining
with monoclonal antibody AP3 (anti-b3 mAb, American Type
Culture Collection), MAb1980 (anti-av mAb, EMD Millipore
Corporation, Billerica, MA), and 37E1 (anti-b8 mAb, a kind gift from
Dr. Nishimura [Nishimura et al., 1994]).
SOLUBLE LIGAND BINDING ASSAY
Soluble ligand binding of Alexa Fluor 488-labeled human
vitronectin and ﬁbronectin (both from Sigma–Aldrich, St. Louis,
MO) was determined as previously described [Wang et al., 2010].
Brieﬂy, transfected cells were suspended in 20 mM HEPES-buffered
saline (pH 7.4) (HBS) supplemented with 5.5 mM glucose and 1%
BSA were pre-blocked with 1 mg anti-b1 antibody (EMD Millipore
Corporation) on ice for 30 min. Cells were then incubated with
20 mg/mL labeled vitronectin or ﬁbronectin at room temperature in
the presence of different ion conditions. For vitronectin binding,
cells were then stained with MAb1980 on ice for 30 min and labeled
with dylight 633 conjugated anti-mouse IgG antibody (Thermo
Scientiﬁc Pierce, Rockford, IL). For ﬁbronectin binding, cells were
incubated with Alexa Fluor 543-labeled AP3 on ice for 30 min.
Binding activity was presented as the percentage of the mean
ﬂuorescence intensity (MFI) of ligands staining relative to the MFI of
MAb1980 or AP3 staining.

RESULTS
EXPRESSION AND SOLUBLE VITRONECTIN BINDING OF INTEGRIN
avb8 ON THE CELL SURFACE
It has been proposed that integrins normally assume a bent
conformation with low afﬁnity for ligands on the cell surface
whereas extracellular stimuli activate integrin from cytosol and
induce extension with high afﬁnity toward soluble ligands [Luo et al.,
2007; Shattil et al., 2010; Wang and Luo, 2010; Kim et al., 2011; Hu
and Luo, 2013]. However, based on the fact that there is no binding site
on the b8 cytoplasmic domain for the inside-out activators, we
proposed that avb8 integrin may adopt a different conformation with
high afﬁnity to its ligands under physiological conditions. To verify
our hypothesis, we ﬁrst expressed integrins avb3 and avb8 in the 293T
cells, and used antibody staining to conﬁrm their expression on the
cell surface. As shown in Figure 1A, av-speciﬁc MAb1980 bound both
transfectants well. The anti-b3 mAb AP3 bound to 293T cells
expressing avb3 only, but not avb8 and control cells, conﬁrming
previous observation that there was no endogenous avb3 expression
in 293T cells. By contrast, the anti-b8 mAb 37E1 bound cells
transfected with avb8, indicating efﬁcient expression and proper
folding of the integrin on the cell surface (Fig. 1A).
To determine the ligand binding capacity, soluble ligand binding
assay was performed using Alexa-488 labeled recombinant human
vitronectin (Fig. 1B). As expected, avb3 bound little soluble
vitronectin in the presence of Ca2þ, whereas the presence of Mn2þ
increased the binding signiﬁcantly. By contrast, integrin avb8 bound
soluble vitronectin in the presence of Ca2þ at maximal level, even
better than that of avb3 in Mn2þ. Addition of Mn2þ did not further
increase binding ability, suggesting that most population of this
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integrin has already adopted a high afﬁnity state under physiological conditions.
We noticed that in a recent publication, a puriﬁed disulﬁde-linked
extracellular fragment of avb8 integrin expressed marginal afﬁnity
for vitronectin [Ozawa et al., 2016] which is inconsistent with our
observation and the previous report [Nishimura et al., 1994]. We
believe that this contradictory may be caused by the artiﬁcially
introduced disulﬁde-bond which restricted separation of the b8 leg
from the av subunit, leading to a structural alternation on the ligand
binding head domain.
THE ECTODOMAIN LOWER STALK OF b8 IS IMPORTANT FOR THE
HIGH AFFINITY STATE
This high afﬁnity of b8 integrin could be caused by the ligand
binding head domain or the lower leg or by both. We therefore
created a chimera swapping the b8 lower leg with that of the b3 to
determine whether this region plays important role in the
constitutively high afﬁnity state. The chimera showed about 30%
lower binding in comparison to the wild-type b8, indicating this
region’s critical role in maintaining high afﬁnity conformation
(Fig. 1C).
The lower leg of b integrin is composed by four EGF-like
domains (I-EGF1–4), a bTD domain, a TM domain, and a short
cytoplasmic tail. We created b3b8 chimeras in which the whole b3
lower leg or only the TM-cytoplasmic domains were swapped with
the corresponding b8 domains (Fig. 2A). The inherent low afﬁnity
of b3 integrin at resting state can provide a better sensitivity in
studying the roles of b8 lower leg domains. Soluble ligand binding
assay was performed to test ligand binding ability of the chimeras
(Fig. 2B). We used human ﬁbronectin labeled with Alexa-488
instead of vitronectin because ﬁbronectin is more affordable, well
studied, and more importantly, unlike vitronectin as shown in
Figure 1, the basal binding of integrin avb3 to soluble ﬁbronectin
is very low under the physiological Ca2þ condition. Therefore,
ﬁbronectin is more sensitive to identify potential change of the
ligand binding. As expected, the wild-type avb3 bound soluble
ﬁbronectin poorly in the presence of Ca2þ, whereas the addition of
Mn2þ signiﬁcantly increased the binding capability. By contrast,
the chimera containing the whole b8 lower leg (b3b8Leg) bound
soluble ﬁbronectin with much higher capability in the presence of
Ca2þ, comparable to the wild-type avb3 in Mn2þ (Fig. 2B),
implicating a potent activating effect of the region. In contrast, the
chimera with the b8 TM and cytoplasmic domains (b3b8TM-Cyt)
showed only moderately increased binding to soluble ﬁbronectin
under Ca2þ condition. The results suggested a critical role of the b8
lower ectodomain stalk, which consists of four EGF domains, in
high ligand binding afﬁnity. Indeed, swapping in only the lower
stalk (b3b8EGF-bTD) was sufﬁcient to promote ligand binding to
a similar level as the whole leg swapping chimera (Fig. 2C). We
also noticed that although both b3b8Leg and b3b8EGF-bTD
expressed high afﬁnity for soluble ligands, the binding could be
further enhanced by addition of Mn2þ. This suggests that
swapping in the b8 lower stalk may shift the conformation
equilibrium toward high afﬁnity state, whereas Mn2þ activated the
remaining integrin population that resides in low afﬁnity state.
Taking together, these discoveries strongly indicated that the b8
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Fig. 1. Expression and soluble ligand binding of integrin b8 and b8b3 chimera. A. HEK293T cells were transfected with either avb3 or avb8 and stained with MAb1980 (anti-av
antibody), AP3 (anti-b3 antibody), and 37E1 (anti-b8 antibody), respectively. Bold-solid line: untransfected HEK293T cells; thin-dashed line: transfected cells. B. Binding of
Alexa A488 labeled vitronectin to HEK293T cells transiently transfected with either avb3 or avb8 in the presence of EDTA (5 mM), Ca2þ (5 mM), or Mn2þ (1 mM) as indicated. C.
HEK293T cells were transiently transfected with the chimera containing a b8 ligand binding head domain and a full length b3 lower leg (b8b3Leg) and tested for Alexa A488
conjugated vitronectin binding together with wild-type b3 and b8 in the presence of EDTA (5 mM), Ca2þ (5 mM), or Mn2þ (1 mM) as indicated. Error bars represent standard
deviation (S.D.) from at least three independent assays.
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Fig. 3. Effect of different ionic conditions on integrin mediated vitronectin
binding. A. Binding of Alexa A488 labeled vitronectin to HEK293T cells
transiently transfected with either avb3 or avb8 in the presence of different
ion conditions as shown on the Figure. B. Binding of Alexa A488 labeled
vitronectin to HEK293T cells transiently transfected with either avb3 or avb8
under gradually increased Mg2þ concentrations. Error bars represent standard
deviation (S.D.) from at least three independent assays.

lower ectodomain stalk is important for the overall high afﬁnity
conformation.

Fig. 2. The b3b8 chimera carrying the b8 ectodomain lower stalk showed high
ligand binding. A. The b3b8 chimeras were created by swapping different b3
domains with the corresponding b8 domains. b3b8Leg: the construct contains
the b3 head domain with the b8 ectodomain lower stalk (I-EGF domains and
bTD domain) and the b8 TM-Cytoplasmic domain. b3b8EGF-bTD: the
construct contains the chimeric b3 integrin which carries the b8 ectodomain
lower stalk. b3b8TM-Cyt: the construct contains the b3 integrin ectodomain
with the b8 TM-Cytoplasmic domain. B. Binding of Alexa A488 labeled
ﬁbronectin to HEK293T cells that were transiently transfected with the wildtype b3 or different b3b8 chimeras in the presence of EDTA (5 mM), Ca2þ
(5 mM), or Mn2þ (1 mM) as indicated. The b3b8Leg chimera showed much
higher ligand binding ability by comparing to the wild-type and
b3b8TM-Cyt. C. Binding of Alexa A488 labeled ﬁbronectin to HEK293T
cells that were transiently transfected with different b3b8 chimeras in the
presence of EDTA (5 mM), Ca2þ (5 mM), or Mn2þ (1 mM) as indicated. The
chimera containing b8 exofacial lower stalk but not TM and cytoplasmic
domains (b3b8EGF-bTD) expressed similar afﬁnity as the b3b8Leg chimera.
Error bars represent S.D. from at least three independent assays.
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Ca2+ IS ESSENTIAL FOR INTEGRIN aVb8 MEDIATED LIGAND
BINDING, WHEREAS Mg2þ INHIBITS LIGAND BINDING AT LOW
CONCENTRATIONS BUT ENHANCES IT AT HIGHER CONCENTRATIONS
Previous studies indicated that Mn2þ and Mg2þ are positive
regulators of integrin ligand binding for most integrins [Mould,
1996], by the interaction of the cations with MIDAS on the a I or b I
domain and by competition of Mn2þ against Ca2þ at ADMIDAS, a
negatively regulatory site when occupied by Ca2þ, respectively
[Zhang and Chen, 2012]. However, these studies have all been carried
out in integrins expressing low afﬁnity under physiological
conditions. We therefore tested afﬁnity states of integrin avb8
with Alexa 488 labeled vitronectin under various ion conditions and
used avb3 as a comparison (Fig. 3a). The results clearly suggested a
dramatically different role of Mg2þ on avb8 regulation. Addition of
Mg2þ at 1 mM concentration reduced ligand binding by about 30%
from the level of Ca2þ only condition for avb8. In contrast, the ligand
binding of avb3 did not change after addition of Mg2þ. Furthermore,
chelating Ca2þ with 1 mM EGTA in the presence of Mg2þ completely
ablated ligand binding of the avb8 integrin. We further studied the
effects of Mg2þ in a concentration dependent manner (Fig. 3b).
The results indicated that low concentration of Mg2þ could reduce
ligand binding in avb8. However, appearance of Mg2þ at high
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Fig. 4. The unique ADMIDAS plays a critical role in b8 integrin mediated ligand binding. A. Sequence alignment of MIDAS (Bold), ADMIDAS (Bold and underlined), and SyMBS
(Underlined) between all b integrins. Note that the b8 ADMIDAS is distinct from others. B. Binding of Alexa A488 labeled vitronectin to HEK293T cells transiently transfected
with different avb3 or avb8 constructs in the presence of different ions as indicated. Error bars represent standard deviation (S.D.) from at least three independent assays.

concentration (>5 mM) restored the avb8 ligand binding to a level
similar to the Ca2þ only condition. Our results suggested that Mg2þ
at low concentration inhibits interaction between avb8 and its
ligand, but this inhibitory effect could be reversed by high
concentration of Mg2þ. Therefore, we propose that there is another
Mg2þ binding site other than MIDAS in the b8 integrin. The site has a
lower afﬁnity for Mg2þ and can only be occupied at high ion
concentration, and the occupancy of Mg2þ at this site could promote
afﬁnity of the b8 integrin toward its ligand. More study is needed for
a better understanding of this potential ion binding site.
THE UNIQUE ADMIDAS CONTRIBUTES TO HIGH AFFINITY FOR
SOLUBLE LIGANDS OF b8 INTEGRIN
Due to the importance of the cation regulation of integrins, it is
possible that the high afﬁnity of avb8 is also caused by the ion
coordinating sites. By comparing the primary sequences of beta
integrin subunits, we found that the ADMIDAS domain on b8 is
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unique among all the beta integrins (Fig. 4A). The two Asp residues
which are universal at ADMIDAS in all other integrins are replaced
with two Asn (Asn120 and Asn121). Since Asn is polar instead of
negatively charged under physiological conditions, this unique
ADMIDAS likely plays a distinct role in integrin afﬁnity regulation.
We therefore designed two mutants: b3Asp126_127Asn (b3N) and
b8Asn120_121Asp (b8D), to study the effect of this speciﬁc residue
replacement (Fig. 4B). The results indicated that mutating b3
ADMIDAS did not cause signiﬁcant change, and Mn2þ could
increase ligand binding of the b3N mutant similar to the wild type.
By contrast, replacing the two Asn with Asp at b8 ADMIDAS reduced
ligand binding and this negative effect was more prominent in the
presence of Mg2þ. Our result suggests that the lower negativity of the
b8 ADMIDAS may play an important role on stabilizing the integrin
in high afﬁnity conformation.
We further tested the effects of Mg2þ in b8 mediated ligand
binding with several chimeric/mutant b8 construct. The b8b3Leg is
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Fig. 5. b8 ADMIDAS is a potential regulatory site of Mg2þ. Binding of Alexa
A488 labeled vitronectin to HEK293T cells transiently transfected with
different avb8 constructs under gradually increasing Mg2þ concentrations as
indicated. Note that the ADMIDAS mutation greatly jeopardized the ability of
high concentration Mg2þ to promote ligand binding. Error bars represent
standard deviation (S.D.) from at least three independent assays.

comprised by a complete b8 head domain and a b3 lower leg, whereas
b8b3LegD is an ADMIDAS mutant of b8b3Leg, carrying the
Asn120_121Asp mutation. We already observed reduced ligand
binding in b8b3Leg (Fig. 1C). However, with the ADMIDAS mutation
incorporated into the chimera, we managed to found further
decreased binding of soluble vitronectin, suggesting that both the b8
ADMIDAS and its leg independently contribute to the high afﬁnity
state (Fig. 5). Moreover, since b8b3Leg showed similar susceptibility
to high Mg2þ concentration with the wild type, our result suggests
that the Mg2þ regulatory site is unlikely located on the lower leg of
the b8 integrin. We further discovered that on both ADMIDAS
mutants, high Mg2þ concentration can only moderately promote
ligand binding by comparing with the wild-type and the leg
swapping chimera. This suggested that the ADMIDAS mutation
reduced the capacity of high concentration Mg2þ to promote ligand
binding, making the b8 ADMIDAS a very plausible candidate of the
hypothesized Mg2þ binding site.

DISCUSSION
Two b3 integrins (aIIbb3 and avb3) have been widely studied as
models for integrin bidirectional signaling. On the contrary, little is
known about the b8, which also associates with av integrin and
belongs to arginine–glycine–aspartic acid receptor family. Its
afﬁnity and conformational states still remain elusive. In this study,
we identiﬁed integrin b8 as the ﬁrst integrin to express high afﬁnity
for soluble ligands under physiological conditions. We also
discovered that both the head and the leg of the integrin contribute
to this high afﬁnity state. By using the chimeras that combined the
ligand binding head domain of the b3 integrin with different
domains of the b8 integrin leg, we revealed an important role of b8
ectodomain lower stalk in the high afﬁnity conformation. We also
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discovered that the ADMIDAS on b8 integrin is strikingly different
from all other b integrins, as the two highly conservative, negatively
charged Asp are replaced with Asn at b8 ADMIDAS. Our mutagenesis
study suggested that this difference may contribute to the high
afﬁnity conformation of avb8.
It has been shown that many integrins adopt a bent conformation
with low afﬁnity for ligands in resting state and can be converted into
extended, high afﬁnity conformation upon inside-out activation [Luo
and Springer, 2006; Kim et al., 2011]. Our study indicated that the b8
integrin is an exception. This integrin lacks all the identiﬁed binding
sites of the integrin cytosolic activators, indicating that the integrin is
unable to be activated from the cytosol. In this study, our experiments
showed that b8 integrin expressed high afﬁnity for soluble ligands
even under physiological conditions. Therefore, this integrin may not
necessarily rely on intracellular signal-induced conformational
change to switch into a high afﬁnity state and become functional.
This is the ﬁrst integrin that has been shown to exist in an active state
under physiological conditions. The discovery has many important
implications for the mechanism of the integrin conformational
regulation as well as the relationship between the integrin signal
transduction and diverse biological functions.
The b integrin lower leg is comprised by several domains.
Previous studies have shown that the disruption of the cytoplasmic
domain association and afterward dissociation of the TM domain are
essential in integrin activation, making the TM/cytoplasmic domains
the most important regulatory sites during integrin activation
[Hughes et al., 1996; Zhu et al., 2007; Hu and Luo, 2015]. However,
our results suggested that in b8 integrin, the TM domain and
cytoplasmic tail do not play a key role in maintaining high afﬁnity
conformation. In contrast, the ectodomain lower stalk, which is
comprised by the EGF domains and bTD, is sufﬁcient to transform
the b3b8 chimera into high afﬁnity state. On the plasma membrane,
integrins are proposed to dynamically adopt three conformational
states: bent-closed, extended-closed, and extended-open [Luo and
Springer, 2006]. These three states are believed to coexist in a
dynamic equilibrium whereas ligand interaction or inside-out
activation alters the equilibrium toward extended-open conformation [Chen et al., 2010; Springer and Dustin, 2012]. It is plausible that
the lower leg of b8 integrin shifts the equilibrium toward extendedopen state. The lower b leg is believed to bend sharply between the
EGF1 and EGF2 domains under physiological conditions, forming a
b knee which is extended and straightened during integrin
activation [Zhu et al., 2008]. Since the EGF domains are crucial in
integrin conformational change, it is possible that the b8 EGF
domains, especially the EGF 1–2, are important in stabilizing the
high afﬁnity conformation.
Metal ions have been shown to play a critical role in integrin
afﬁnity regulation [Luo et al., 2007; Zhang and Chen, 2012]. Three ion
binding sites have been identiﬁed on beta integrin head: MIDAS,
ADMIDAS, and SyMBS. Cation occupancy in MIDAS is known to
direct ligands binding through coordinating negatively charged
carboxyl group of the ligands. In contrast, it has been reported that
ADMIDAS can only be bound by Ca2þ and Mn2þ, and the ligand
binding ability can be inhibited by Ca2þ occupancy or promoted by
Mn2þ occupancy [Chen et al., 2003; Mould et al., 2003; Pesho et al.,
2006]. However, the previous studies had been carried out in integrins
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adopting low afﬁnity conformation at resting state. We have shown
that b8 integrin adopts a high afﬁnity state in the presence of Ca2þ and
therefore, the metal ions may regulate the integrin in a different
manner. Indeed, our study showed that the b8 ADMIDAS is critical for
high afﬁnity conformation of the integrin. We also found that low
concentration of Mg2þ inhibited b8 integrin for ligand binding,
whereas high concentration of Mg2þ promoted ligand binding. The
discovery suggests the existence of another Mg2þ binding site rather
than MIDAS on the b8 head domain. The unique b8 ADMIDAS might
be occupied by Mg2þ at high concentration and this occupancy can
promote b8 mediated ligand binding. The extracellular calcium with
mM concentration plays a vital role in nervous system [Simons, 1988;
Burgoyne and Haynes, 2012]. Peripheral nerve is exposed to
extracellular ﬂuid which contains about 1–2 mM Ca2þ; whereas
central neurons are bathed in an interstitial ﬂuid with about 1 mM
Ca2þ. Changes in the calcium concentration have a profound effect on
neuronal functions. On the other hand, magnesium may have more
complex effects on neuronal functions [Lee et al., 2010]. It is possible
that the b8 ADMIDAS might have an essential role in sensing a
ﬂuctuating environmental ion condition as this integrin lacks a
cytosolic “on/off” switch.
In conclusion, our research revealed for the ﬁrst time that the b8
integrin adopts a constitutively high afﬁnity state toward its soluble
ligands under physiological conditions. Our study showed that both the
b8 ectodomain lower stalk and its unique ADMIDAS are important for
this high afﬁnity conformation. One of the most important biological
roles of the b8 integrin is mediating maturation and activation of TGFb1. This is achieved through binding to latent TGF-b1 and introducing
membrane type 1 metalloprotease dependent active TGF-b1 release
[Mu et al., 2002]. Since the b8 cytoplasmic tail lacks binding sites for all
the known integrin cytosol activators, it is most likely that the only way
for this integrin to efﬁciently bind latent TGF-b1 is to maintain high
afﬁnity state under physiological conditions. In fact, a recent study
showed that recombinant integrin avb8 extracellular domain indeed
strongly interacts with latent TGF-b1 [Ozawa et al., 2016]. However,
more research is required to conﬁrm if the high afﬁnity conformation is
indispensable for b8 to function properly.
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